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Abstract
Nephrolithiasis, or stones, is one of the oldest urological diseases, with descriptions and treatment 
strategies dating back to ancient times. Despite the enormous number of patients affected by 
stones, a surprising lack of conceptual understanding of many aspects of this disease still exists. 
This lack of understanding includes mechanisms of stone formation and retention, the clinical 
relevance of different stone compositions and that of formation patterns and associated 
pathological features to the overall course of the condition. Fortunately, a number of new tools are 
available to assist in answering such questions. New renal endoscopes enable kidney visualization 
in much higher definition than was previously possible, while micro-CT imaging is the optimal 
technique for assessment of stone microstructure and mineral composition in a nondestructive 
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fashion. Together, these tools have the potential to provide novel insights into the aetiology of 
stone formation that might unlock new prevention and treatment strategies, and enable more 
effective management of patients with nephrolithiasis.
Nephrolithiasis is the most costly urological disease1 and warrants intensive research efforts 
directed towards both prevention and treatment. Greater insight into the mechanisms of 
stone formation is critical, and an improved understanding of the aetiology of stone 
development and growth would enable researchers and clinicians to develop novel ways of 
slowing, and possibly even preventing this process. A number of novel tools have been 
introduced over the past several years with the potential to improve our understanding of the 
aetiology of nephrolithiasis, most notably, high-definition renal endoscopy and micro-CT. In 
this Perspectives article, we describe the development and clinical use of these technologies, 
focusing in particular on how they might complement existing modalities used to study 
kidney stones and to classify stone formers.
Current limitations in classification
Analysis of stone mineral composition and assessments of the presence of these same 
minerals and metabolites, such as calcium, oxalate and uric acid in 24-h urine samples are 
currently the two most commonly used tools for the characterization of stone formers. Both 
of these approaches are recommended in the evaluation of stone formers with a high risk of 
recurrence2,3 and both have considerable limitations and potential for inaccuracies. The 
main limitation of stone analysis is that current methods, such as Fourier transform infrared 
spectroscopy (FT–IR), require destruction of the stone. Thus, this type of analysis denies 
investigators the opportunity to investigate the morphology of the stone, or the distribution 
of mineral subtypes once it has been analysed. Other analysis methods also exist, and these 
vary in their utility, costs and reliability. Such methods include radiographic powder 
diffraction, Raman spectroscopy, scanning electron microscopy and thermal analysis4–8. 
Given the large number of techniques available, each with their own limitations, a surprising 
lack of consensus statements or guidelines advocating the optimal approach towards stone 
analysis currently exists.
FT–IR is currently the favoured stone analysis modality at most large medical centres owing 
to the generally high reliability of this technique; however, investigators often fail to 
appreciate that this technique is only performed on a representative stone fragment as 
opposed to the entire specimen supplied to the laboratory. This approach would not be of 
any concern if most stones were of a homogenous composition; however, this is rarely the 
case. In fact, among >10,000 stones analysed in France by Daudon et al.9 only 7% were 
found to be composed of a single mineral9. As a result, analysis of a stone fragment and not 
the entire stone creates a considerable risk of sampling bias, depending upon the part of the 
stone that is analysed. Krambeck et al.10 tested this hypothesis by fragmenting 25 different 
stones and sending representative pieces to five different commercial stone analysis 
laboratories in the USA. These investigators found that results of the analyses of the 
composition of pure stones, consisting of a single substance, were highly reproducible; 
however, considerable discrepancies in the reported composition of different fragments of 
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the same stone were observed following the analyses of stones of a mixed composition. 
Furthermore, this study demonstrated particularly poor reproducibility in correctly 
identifying struvite (struvite was universally identified in only two of four known struvite-
containing stones) and apatite (apatite was not detected in 20% of fragments from known 
apatite-containing stones)10.
Chemical analyses of 24-h urine samples are similarly problematic as a tool for 
appropriately classifying stone formers. Generating a 24-h urine sample requires a high 
degree of patient compliance. As a result of this need for patient compliance, estimates 
published in 2015 show that samples might be inappropriately collected as often as 50% of 
the time in non-research settings11. Even when performed correctly, results can be widely 
variable depending upon patients’ diet, hydration status, physical activity, medication use 
and other factors specific to that 24-h period12. For this reason, considerable debate exists 
within the urology and nephrology communities as to whether a single collection should be 
considered sufficient for the comprehensive clinical workup of a patient with 
nephrolithaisis12–16.
The inherent flaws of these two widely used analysis methodologies makes the 
subclassification of stone formers very challenging and also presents a limitation to future 
stone research. As our level of insight into the aetiology and pathogenesis of stones 
continues to expand, investigators are increasingly becoming aware that stones are a 
common end point of a number of unique pathophysiological processes and diseases that are 
likely to require unique treatment strategies17–19. The identification of these unique 
pathologies associated with stone formation, followed by attempts to individualize 
treatments to the specific disease subtypes, will be critical next steps in stone research. New 
tools such as high-definition renal endoscopy and micro-CT have the potential to help 
achieve this goal.
High-definition renal endoscopy
The introduction of smaller endoscopes with high-definition digital imaging capabilities has 
been one of the greatest advances in the endoscopic treatment of renal stones. Such 
endoscopes not only offer unparalleled access to the renal collecting system, thus enabling 
visualization of each individual papilla, but also provide superior optics, wider fields of 
view, higher resolution and, overall, an improved ability to examine the tissue compared 
with that of conventional endoscopes20–23.
Technological advances
The development of charge-coupled devices (CCD) and complementary metal oxide 
semiconductor (CMOS) sensors, which convert optical light to a digital signal, has been 
critical to the development of high-definition endoscopes23,24. Before the availability of this 
technology, older-generation fibre-optic ureteroscopes were used, which process optical 
images from a lens located at the distal tip of the instrument followed by relaying of the 
image through the instrument to a camera head, where it is processed and projected onto a 
video monitor. The numerous interfaces and cables required for this process introduce the 
potential for interference and distortion of the image25. Newer-generation digital 
Borofsky et al. Page 3
Nat Rev Urol. Author manuscript; available in PMC 2018 April 02.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
ureteroscopes, however, feature CCD and/or CMOS chips on the tip of the endoscope, which 
enable immediate digitization of the image and direct transmission to a video display, 
therefore eliminating the interfaces at which a loss of image quality most commonly 
occurs26. (FIG. 1) Besides these improvements in image resolution, these ‘chip on a stick’ 
advances have enabled a greater extent of image magnification, use of greater light intensity, 
and improved image capture and video recording20,21. Furthermore, the benefits of improved 
optics have not come at the expense of increased scope size or a loss of manoeuverability, 
hence, these modern scopes retain the ability to access the entirety of the renal collecting 
system27.
Papillary inspection
Inspection of the renal papillae, performed at the time of stone removal either using a 
ureteroscope during flexible ureteroscopy or a nephroscope during percutaneous 
nephrolithotomy is an often underappreciated aspect of renal endoscopy that might provide 
clues as to why that patient is forming stones. Normal papillae have entirely smooth, 
rounded, surfaces and are conical in shape except when compound or fused with an adjacent 
papilla. Barely visible openings to the ducts of Bellini and minimal-to-no interstitial mineral 
deposition are common features of the renal papillae of individuals with no history of 
nephrolithiasis (FIG. 2). However, papillary appearance in stone formers often varies from 
this ‘classical’ description and includes unique findings, such as mineral deposition and 
changes in papillary architecture and shape18,28. These changes are generally easy to 
identify with modern digital scopes but difficult to describe18,29,30.
Presumably, the ‘abnormal’ appearance of the papillae in stone formers is a direct 
consequence of stone formation, given the general consensus among experts that the renal 
papilla is the site of origin of many, if not most stones. This consensus is especially true of 
patients who form calcium stones18. Idiopathic calcium oxalate stones, defined as those 
predominantly composed of calcium oxalate in the absence of systemic disease, are not only 
the most abundant type of stone but also the type with the greatest degree of evidence 
supporting the papilla as a site of stone formation. In such instances, papillary mineralization 
(Randall plaque) has been demonstrated to act as a nidus for calcium oxalate stone 
overgrowth on both endoscopy and biopsy sample analysis, thus supporting a link between 
endoscopic papillary pathology and stone formation31–33. Papillary appearance might also 
provide unique information in instances where the stones are not believed to originate from 
the papilla. For example, papillary appearance in stone formers that form struvite34 or uric 
acid stones35 is distinct from that of individuals who do not form stones. Currently, our 
understanding of the clinical significance of papillary abnormalities remains limited, 
although the advent of high-definition renal endoscopy opens many opportunities for future 
investigations in this area.
To date, high-definition renal endoscopy has been used in the characterization of a number 
of unique stone-forming diseases, including, among many others, primary 
hyperparathyroidism and distal renal tubular acidosis36–45. A number of distinct 
mechanisms of stone formation have been identified in the process of investigating these 
diseases, with visual correlates that can be observed grossly at the level of the papilla. The 
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two most commonly identified abnormalities of this type are Randall plaques and ductal 
plugs, each of which is a distinct pathway towards the growth of calcium stones18,19.
Investigations in this area date back to work by Alexander Randall, who first described 
papillary mineral deposition in the 1930s after examining >1,000 human kidneys at 
autopsy46. In the years since then, two distinct types of papillary mineralization patterns 
have been identified. The most well studied are Randall plaques, which begin as apatite 
mineral deposition in the thin descending limbs of the loop of Henle that subsequently 
extend outwards into the surrounding interstitium and ultimately erode into the urinary 
space. Once in contact with urine, this type of mineral deposition forms a site of stone 
overgrowth through a mechanism that remains largely unclear41. Classically, stones that 
grow on Randall plaques are composed of calcium oxalate. Visually, Randall plaques appear 
as white suburothelial mineral deposits that can be either focused around the tip of the 
papilla or scattered across its surface. To date, the amount of Randall plaques identified at 
the time of nephroscopy has been shown to directly correlate with the extent of stone-
forming activity47, thus adding to the potential clinical utility of observing and noting 
papillary appearance during renal endoscopic procedures.
The other type of papillary mineralization, ductal plugs, are also most commonly composed 
of apatite, but instead of being white, are distinctly yellow in appearance. These yellow 
mineral deposits occur within the lumina and ducts of the renal collecting system as opposed 
to within the tissue itself18 and are identifiable as large yellow mineral deposits extending 
from the ducts of Bellini into the urinary space. Such ductal plugs can frequently be seen 
under the surface of the urothelium as yellow mineral deposits within the inner medullary 
collecting ducts that have not yet reached the distal end at the level of the urinary space. 
These mineral deposits often extend in a ‘spoke-wheel’ pattern from the tip of the papilla to 
the calyceal fornix. Ductal plugs are well described in renal biopsy specimens, particularly 
from patients with certain types of stone composition (brushite or hydroxyapatite), or stone-
forming diseases (renal tubular acidosis and primary hyperparathyroidism); however, their 
ability to directly contribute to clinical stone formation remains speculative18,36,39,42,44. The 
presence of ductal plugs, however, can be easily visualized using high-definition renal 
endoscopy and these are morphologically distinct from Randall plaques. The presence of 
this mineralization pattern, compared with Randall plaques, is also indicative of different 
underlying patterns of stone formation.
In a study comparing patients with idiopathic calcium oxalate stones (ICS) to those with 
idiopathic hydroxyapatite stones (HAS), the relative degrees of Randall plaque and ductal 
plug formation were demonstrated to enable greater discrimination between these two 
groups of patients than chemical analyses of urine content alone. Patients with ICS had an 
average of 8% coverage of the papillary surface by Randall plaques compared with <1% 
among patients in the HAS cohort44. Conversely, the HAS cohort had a much greater 
number of ductal plugs (12 per mm3) within the papilla compared with no plugging in the 
ICS cohort44. The overall significance of the presence of ductal plugs remains an active area 
of current research, particularly whether or not their presence indicates the existence of an 
underlying systemic stone-forming disease.
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Micro-CT imaging
Micro-CT is a nondestructive, in vitro laboratory method that enables 3D visualization of 
small structures (<10 cm in diameter) to a resolution 1,000 times finer than is possible using 
a clinical CT scanner48. Different minerals in urinary stones generally possess distinct 
radiographic attenuation values49, these minerals can be easily detected and identified using 
micro-CT in most kinds of urinary stones, including those of a heterogeneous 
composition48,50. Like most other forms of CT imaging, micro-CT yields a 3D 
representation of the object. Thus, the micro-CT reconstruction of a stone can be rendered to 
reveal the surface features of the stone, or sliced in any plane to reveal the internal structure. 
The 3D image can also be quantitatively segmented for measurement of the volumes 
occupied by different mineral types.
Micro-CT of stones
Data from micro-CT imaging enables reconstruction of a fragment retrieved during 
percutaneous removal of a renal pelvic stone (FIG. 3). The scan for this fragment took 20 
min, followed by 18 s for graphics-card-accelerated tomographic reconstruction. The system 
we use is capable of scanning such a specimen to voxel sizes as small as 0.9 μm, but such a 
high-resolution scan would require >3 h to complete, and the resulting image stack would be 
>50 GB in size, making it impractical to visualize on most computer systems.
Several characteristics make micro-CT a valuable technique for the study of urinary stones: 
micro-CT enables microscopic imaging of entire stones, and in a nondestructive manner, so 
that the stone can also be subjected to more conventional methods of analysis after micro-
CT, if desired. Micro-CT also enables most minerals in the stone to be distinguished by their 
distinctive radiographic absorption properties and can enable the visualization of crystal 
structures, thus providing additional information that can be helpful in identifying stone 
minerals51. Micro-CT provides images with a very high level of resolution, thus enabling 
imaging of structures of only a few microns in size. When minerals are segmented based 
upon radiographic attenuation values, micro-CT can be used to easily quantitate the 
percentages of the total volume of the stone composed of each type of mineral. Finally, 
because micro-CT produces 3D image stacks that are isotropic (that is, the image voxels are 
cubic in shape), the 3D image can be resliced in any desired plane. This possibility enables 
the investigator to minutely examine the structures within a stone in exquisite detail.
Micro-CT offers some unique benefits when compared with FT-IR, which is one of the most 
widely used and accepted means of assessing the mineral content of kidney stones4. One 
particular advantage of micro-CT is the nondestructive nature and ability to define 
microstructural aspects of the stone being analysed. This new approach would be limited if it 
was unable to accurately characterize stone mineral composition; however, micro-CT 
compares favourably to FT-IR in this regard.
Our group has been utilizing micro-CT as a complement to FT-IR for much of the past two 
decades. In unpublished data from our institution comparing FT-IR and micro-CT analysis 
of 472 unique human kidney stones, the two modalities demonstrated similar accuracy. 
Analysis using FT-IR correctly identified the mineral composition of 87.5% of specimens, 
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and analysis using micro-CT correctly identified the composition of 86.4% of 
specimens52,53. More than half of the stones that were misidentified using micro-CT were 
misidentified owing to the presence of uncommon stone mineral subtypes (such as 
whitlockite, urates or drug-related minerals). The remaining misclassifications reflected 
false identification of, or a failure to identify struvite. This limitation is probably attributable 
to the fact that struvite is commonly observed as an admixture among stones also containing 
several other mineral components, which can make interpretations of data from micro-CT 
imaging challenging. Interestingly, FT-IR was also found to miss minor stone components 
such as high-density apatite, a component that was accurately identified using micro-CT, 
thus further illustrating the complementary nature of these two modalities. The future of this 
technology holds promise, although several limitations should also be considered including 
the substantial upfront costs of the micro-CT scanner itself, the increased time demands to 
properly process specimens, as well as the lack of a standardized nomenclature to describe 
microstructural mineralization patterns and findings.
Practical utilization
As part of an ongoing NIH-sponsored research study, our group has meticulously 
characterized stone formation in >300 patients54. Our techniques have evolved over the 
course of this investigation and now include high-definition renal endoscopy and micro-CT 
as key elements of the optimal assessment of these patients. Our standard practice for a 
patient receiving treatment as part of our research programme includes several components: 
after providing detailed medical, surgical and stone-specific histories, patients undergo 
metabolic evaluation including analysis of the mineral content of serum samples and two 24-
h urine sample collections performed while not receiving any medications that could 
potentially affect baseline physiology. At the time of surgical stone removal, ‘renal mapping’ 
is performed, whereby a high-definition endoscopic video of each papilla is recorded and 
matched with a fluoroscopic depiction of calyceal location (FIG. 4). Unique papillary 
features are described and recorded, including the presence of dilated ducts of Bellini, 
papillary erosion, papillary contour and the presence of mineral deposits (Randall plaques or 
ductal plugs).
Stone basket extraction is an important element of our technique, whereby we attempt to 
remove all stones in the least destructive way possible, such that stone microstructure is 
retained, enabling patterns of stone growth and retention to be studied using micro-CT. Use 
of a ureteral access sheath is necessary to accomplish the goal of stone preservation as 
alternative mechanisms of stone treatment, such as ‘dusting’, do not provide sufficient stone 
samples to enable micro-CT analysis. All stones identified are removed and labelled 
individually, including information on the location of each stone within the kidney, as well 
as whether the stone was attached, freely floating or required fragmentation. Upon 
completion of stone removal, a papillary biopsy sample is obtained. Individually labelled 
stones then undergo evaluation of their composition and structure using micro-CT, and 
papillary biopsy samples are processed and examined for the presence of histopathological 
abnormalities and mineral content.
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Distinguishing plaque-based from plug-based disease
Endoscopic appearances of the renal papillae often reflect stone formation characteristics, 
particularly in patients who form ICS or HAS stones44 (FIG. 5). Patients with ICS generally 
have a greater coverage of Randall plaques on the papillary surface, which are visible as 
superficial white mineral deposits, as opposed to the more dense yellow mineral deposits 
commonly seen in those with HAS (FIG. 5). These distinct papillary appearances often also 
correlate with differences in stone microstructure. For example, two attached stones of 
similar size were taken from different patients. Both of these stones were attached to the 
renal papilla, but the mode of attachment — and the underlying process of stone formation 
— was quite different between the two18 (FIGS 6,7).
The first of these two patients had 17 unique calcium oxalate stones removed during 
bilateral ureteroscopy. The majority of these stones were attached to the papillae and all 
showed evidence, on endoscopic or micro-CT, of having grown on Randall plaques (FIG. 
6a). Examination of the kidneys during this procedure found all papillae to be normal in 
shape and appearance, with the exception of Randall plaques, which were evident on the 
majority of papillae (FIG. 5a). A metabolic workup did not reveal any underlying systemic 
disease and the patient was thus characterized as an idiopathic calcium oxalate stone former.
The second patient also had numerous bilateral calculi, although this patient also had a 
known diagnosis of primary hyperparathyroidism. Several stones were found to be attached 
to the papillae, although no evidence of Randall plaques was detected on either endoscopic 
examination or micro-CT. The papillae in this patient had a distinct appearance with 
extensive evidence of yellow ductal plugs and dilated ducts of Bellini, similar to those 
shown in the presented image (FIG. 5b). Findings of micro-CT analysis of the attached 
stones were also distinct with a wide, dense stalk of apatite over which the stone had grown, 
consistent with the appearance of a ductal plug (FIGS 6,7).
A variety of morphological differences between apatite found on Randall plaques, and 
apatite found within the lumina of a duct of Bellini can be observed using micro-CT (FIG. 
7). The stone formed upon a Randall plaque contains spaces that are roughly cylindrical in 
shape, when viewed in 3D, and with typical diameters of 10–30 μm. These spaces likely 
reflect the presence of tubules, around which the apatite deposits probably formed, and are 
consistent with stone formation being an interstitial, as opposed to intratubular or ductal 
process. The apatite within the Randall plaque does not show alternating radiographically 
dense and lucent layers, as is typical of apatite stones51. Instead, the radiographic density of 
the apatite varies within the plaque, being the most dense in the middle and least dense 
toward the periphery of the plaque. In our own experience, rings of apatite can sometimes be 
observed at the edges of a region of the renal papilla containing a high density of Randall 
plaques, which probably indicates the mineralized thin limbs of the plaques protruding 
towards the basement membrane, as has been described for the early stages of Randall 
plaque formation55.
In contrast to apatite accumulation in Randall plaques, the apatite in a ductal plug usually 
shows signs of having accumulated by accretion of layers. The shape of the plug is typically 
cylindrical or oblong, with tapered ends. Sometimes ductal plugs show evidence of having 
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formed from multiple spherical or ovoid shapes (FIG. 7), however, some ductal plugs have 
been observed to be more monolithic, but still with signs of having grown by addition of 
layers44. These two stones provide anecdotal examples of the ways that micro-CT imaging 
of stones, combined with examinations of the renal papillae, can add insight into 
mechanisms of retention and growth of calculi. The diversity of mechanisms of urinary 
stone formation is one of the important lessons that we are learning from studies of patients 
with stones published within the past 6 years19,56.
Taken together, information gained from considerations of papillary pathology and stone 
microstructure on micro-CT hold promise as a way of improving upon current methods of 
classifying stone formers. Using this approach, routinely commenting upon mechanisms of 
stone formation in addition to mineral composition alone might soon become possible. As 
an example, patients with ICSF and primary hyperoxaluria both form calcium oxalate stones 
and would be indistinguishable based upon the results of FT-IR analysis of their stones 
alone. However, patients that form one of these two types of stones have quite distinct 
papillary appearances with Randall plaques commonly observed in ICSF and rarely, or never 
seen in those with primary hyperoxaluria18. Consideration of these distinctions can, 
therefore, be used to help distinguish the underlying pathophysiology of these patients. 
Similarly, stones commonly have mixed compositions and often contain different amounts of 
apatite and calcium oxalate. As such, FT-IR analysis is prone to error depending on the 
mineral composition of the stone fragment being sampled. Therefore the addition of 
information on microstructural patterns of stone formation (plaques versus plugs) could 
provide more information than mineral analysis alone.
At this point in time, greater efforts are being made to improve the conceptual understanding 
of how papillary pathology is associated with stone microstructure and/or mineral 
composition. Ultimately, improving the ability to properly classify patients on the basis of 
the unique underlying mechanism through which stones are formed has the potential to 
dramatically improve the management of patients with this condition. This concept is not 
new. In fact, mineral analysis alone has revolutionized the medical management of stone 
disease, leading to guidelines such that patients with particular types of stones receive 
directed treatment2. However, much still remains to be learned and the precision with which 
stone formers are currently classified still has the potential for vast improvement, which 
ultimately could lead to more effective care.
Classification of papillary abnormalities
The potential of papillary abnormalities to act as a surrogate marker of the underlying 
disease has been proven among carefully selected patients whose clinical features are 
analysed by a team with experience in this area, although whether or not this approach is 
applicable to the wider urological community currently remains unclear. Over the past 10–
20 years, minimally invasive approaches to the treatment of stone disease have entirely 
replaced open surgical methods57. As such, the majority of urological surgeons now have 
high degrees of comfort, skill and experience in using an endoscope to examine the kidney. 
Despite this change in approach, such procedures almost entirely focus on treatment and 
removal of the stone, with renal papillary inspection remaining an almost entirely 
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unappreciated aspect of the procedure. This lack of implementation of papillary inspection 
could possibly be a result of the widespread use of older-generation instruments that do not 
provide the high level of image resolution provided by modern scopes; although, this deficit 
more likely reflects the fact that, even if papillary abnormalities were commonly 
appreciated, the relevance of these abnormalities is entirely unclear. Hence, the current 
revolution in scope optics is an opportunity, upon which new insights from the wider 
urological community will be necessary in achieving a consensus regarding the normal, 
abnormal and clinically relevant features of the renal papilla. The creation of a common 
language, with which researchers and clinicians alike are able to describe papillary findings 
using the same descriptive terminology, will be a critical element of accomplishing this goal.
Our research team has introduced a grading scale for the purpose of identifying and 
quantifying the presence, extent and type of papillary abnormalities across four distinct 
papillary domains (ductal plugs, ‘pitting’, ‘loss of contour’ and Randall plaques)28. Ductal 
plugs and Randall plaques have been previously described. ‘Pitting’ refers to focal erosion 
or crater-like areas of the papillary surface, which should normally be entirely smooth. ‘Loss 
of contour’ refers to the global flattening of the papilla, which should normally have the 
appearance of a tall hill or mountain peak.
Reproducibility of such a grading system is a critical component in ensuring its 
implementation as a meaningful clinical tool. Early investigation in this regard has 
elucidated the fact that the ability to appreciate the presence and magnitude of such 
abnormalities is not intuitive, but improves with experience and education. In the initial 
description of this system, reproducibility was most favourable when applied by the two 
urologists that were most familiar with using the grading system, thus demonstrating exact 
inter-investigator agreement across all four measured domains in nearly 75% of patients 
studied28. Subsequent efforts examining the reproducibility of this approach among the 
wider urological community have shown that this concept is new even for those who are 
familiar with renal endoscopy. In an unpublished experience, 16 endourologists with no 
prior familiarity using such a grading system were asked to grade nine separate videos of 
unique papillae, each having variable amounts of papillary abnormality. Using a weighted κ 
statistic to quantify interobserver agreement, agreement across all observers was found to be 
moderate for ductal plugs (0.42) and pitting (0.43), but only fair for loss of contour (0.27) 
and Randall plaques (0.20). However, reproducibility might improve with appropriate 
education of clinicians and increased familiarity with the concepts behind the scoring 
system. In a separate analysis58, a senior and junior urologist, neither of whom had 
previously encountered the grading system, were provided with a 1-h dedicated training 
session including example images of various papillae58, and opportunities to clarify any 
questions. Subsequently, videos of a single papilla from 50 separate patients were examined 
by these two urologists, in addition to another senior and junior urologist who were both 
already familiar with the grading scale. Videos were viewed twice to assess the level of 
intra-investigator agreement. In this study, both the intra-investigator and inter-investigator 
levels of agreement were considerably higher across all domains regardless of experience, 
with substantial to near-perfect agreement for assessments of all measured variables 
(weighted κ-statistic for level of agreement >0.6) excluding Randall plaques, for which a 
moderate level of inter-investigator agreement (0.52) was observed58.
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This renal papillary grading system is the composite end point of years of experience and 
attention directed towards this purpose by a team of interested individuals; yet, we readily 
acknowledge the potential for such a system to evolve further. In fact, improved recognition 
of papillary disease is the entire purpose of creating such a grading system and might 
provide a novel tool for the consideration of stone disease on a much larger scale, thus 
enabling widespread collaboration across the urological community. Development and 
utilization of such a system would hardly be unique in medicine. Many established examples 
of comparable grading scales exist, and are used for the similar purposes of characterizing 
disease pathology and guiding treatment. Some of these scales even form the cornerstones of 
disease diagnosis and classification including the Bethesda System for Pap smear grading to 
predict cervical cancer59, the Braden Scale assessments to predict the risk of pressure 
ulcers60, and the Kellgren & Lawrence system for classification of knee osteoarthritis61. In 
fact, the field of urology also already has several similar scales including the Bosniak 
classification system to predict the likelihood of malignancy based upon the complexity of 
renal cysts62 and the renal trauma grading scale to assess damage and guide intervention for 
traumatic renal injuries63.
If a similar papillary grading system for the purposes of subclassifying stone formers was to 
be fully validated, the potential research and clinical utility would probably be enormous. 
Such a grading system would enable researchers to identify patients with specific stone-
forming pathophysiologies and in the process potentially develop better disease-specific 
treatments across multiple clinical domains including optimal dietary, metabolic, 
pharmacological and surgical approaches towards stone prevention and treatment.
Micro-CT also has a promising future. Our previous example focused on using micro-CT as 
a tool to analyse and distinguish papillary stones, however no good reason exists to suggest 
this technique cannot also be used to study alternative mechanisms of stone formation, 
including the assessment of concretions formed in animal models to determine how much 
these resemble human stones. Further research using this technique might help to elucidate 
the mechanisms by which certain stones in humans grow in free solution, help determine the 
potential for calcification of stents and nephrostomy tubes and even provide insight into the 
stone–tissue relationship itself. For example, we have previously performed micro-CT 
analysis of renal biopsy samples whereby the pattern of mineral distribution within the renal 
tissue itself becomes more evident64. Currently, this technology is too costly and demanding 
of resources to be offered as anything more than a research tool. However, as experience, 
familiarity and awareness continue to grow, the possibility emerges that novel ways of 
streamlining costs and practical usage could open up opportunities for utilization of this tool 
on a wider scale. In fact, in many ways a stone removed from a kidney is no different from a 
tissue biopsy sample taken to diagnose other diseases for which advanced and expensive 
techniques, including tissue microdissection, flow cytometry and genetic sequencing, which 
were once seen as radical research tools, are now used routinely.
Conclusions
A variety of underlying pathologies can result in urinary stones, and identification of these 
pathologies and possible treatments for them, will be important to accomplish advances in 
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the treatment of patients with stones in the coming years. High-definition renal endoscopy 
and micro-CT imaging of stone specimens enables further enhancement of our ability to 
discriminate between stone formers that have distinctly different underlying causes of their 
disease, and will undoubtedly be an important aspect of attempts to improve the 
classification of stones in the future.
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Figure 1. Fibre-optic versus digital ureteroscopic images
Images of the renal papilla acquired using a,b | a fibre-optic ureteroscope (KARL STORZ 
FLEX-X2, KARL STORZ, Tuttlingen, Germany) and c,d | a digital ureteroscope (ACMI/
Olympus Invisio DUR-D, Gyrus ACMI, Massachusetts, USA) The enhanced view provided 
by the digital scope allows superior visualization of the papilla including both an attached 
stone as well as nascent mineral which might ultimately become a stone or be related to 
stone formation. The ability to identify such details opens new doors to study associations 
between papillary appearance and stone disease23. Reproduced with permission obtained 
from Elsevier Ltd © Humphreys, M. R. et al., A new world revealed: early experience with 
digital ureteroscopy. J. Urol. 179, 970–975 (2008).
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Figure 2. Digital ureteroscopic image of a classic renal papilla
The surface of the papilla is entirely smooth, round and conical in shape and no mineral 
deposition can be observed.
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Figure 3. Micro-CT imaging and reconstruction of a stone fragment
a | First, the specimen is imaged using a radiation source and an x-ray camera, with a small 
degree of rotation accomplished between consecutive images. In the example shown here, 
the specimen was rotated 0.4° between each image, for a total rotational range of slightly 
more than 180°. The computer then used this series of radiographic images to reconstruct the 
3D structure of the specimen. b | A single reconstructed slice taken through the specimen 
depicted in part a. c | A portion of the same slice as depicted in part b; note that the regions 
of transformation of the calcium oxalate dihydrate (COD) to monohydrate (COM) are quite 
small, in the order of 100 μm in size, but these can be easily observed. Imaging of 
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transformed regions within COD crystals has also previously been described, but only by 
physically cutting sections of the crystals65,66. The COM absorbs radiation with a slightly 
greater avidity than that of COD, therefore the image could be easily segmented to measure 
the portion of the stone occupied by COM. d | Segmentation of COM. When all image slices 
are similarly segmented, the volume percentages of the minerals can be easily calculated. e | 
Surface rendering of the fragment used in this example, note the clarity with which the 
polyhedral crystals of COD are shown.
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Figure 4. Renal mapping of a right kidney using high-definition renal endoscopy
a | Calyceal location and number is denoted on fluoroscopic imaging. b-d | Endoscopic 
images of the upper-pole papillae (UP)s 1-3. e-g | Endoscopic images of the interpolar 
papillae (MP)s. h,i | Endoscopic images of the lower-pole papillae (LP)s. Dilated ducts of 
Bellini are circled in white, asterisk indicates the presence of a yellow ductal plug, no 
Randall plaques are visualized.
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Figure 5. Common renal papillary abnormalities observed in stone formers
Digital endoscopic images showing the papillary appearance of two different patients. a | 
Randall plaquesseen commonly in patients that form idiopathic calcium oxalate stones and b 
| ductal plugs seen commonly in patients who form idiopathic hydroxyapatite stones. In 
these images Randall plaques and ductal plugs are distinguishable by their colour (white 
versus yellow, respectively). Arrows indicate the presence of these abnormalities.
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Figure 6. Comparisons of stones anchored to papillary tissue in two different ways
a | Digital reconstruction of a calcium oxalate stone that accumulated on a Randall plaque. 
The colour inset shows a photograph of the stone on mm-grid paper. Surface rendering and 
sliced stack analyses both reveal the presence of calcium oxalate (grey). The colour of the 
Randall plaque (white) indicates a high level of radiographic attenuation, reflecting the 
presence of apatite. Note the sparse and thin distribution of the apatite comprising the plaque 
itself b | Digital reconstruction of an apatite stone that accumulated on a ductal plug. In this 
image the apatite ductal plug anchoring the stone to the papilla is more substantial, thicker 
and denser compared to that of the Randall plaque indicating a distinct mechanism of 
formation and retention within the kidney at the level of the papilla.
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Figure 7. Direct comparison of reconstructions of stones formed on a Randall plaque or on a 
ductal plug
a | Stone formed on a Randall plaque showing lumina of tubules and/or vessels (as indicated 
by arrows), demonstrating that this apatite region is interstitial. In Randall plaques, apatite 
accumulates in the papillary interstitium, without any deposition into tubular lumina. By 
contrast, the stone formed on a ductal plug. b | conforms to the shape of the dilated duct in 
which it formed, and shows signs of accretion by layering (as indicated by arrowheads). This 
ductal plug seems to have been formed from multiple, small spheres of apatite.
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